(Q74645498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Osteoporosis after organ transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

main subject

organ transplantation

1 reference

M A Rodino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E Shane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

459-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Immunosuppressive therapy and the skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone histomorphometry in glucocorticoid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

The role of testosterone in cyclosporine-induced osteopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Rapid loss of vertebral mineral density after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Changes in bone mass early after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Influence of vitamin D receptor genotype on bone mass changes after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteoporosis and bone morbidity in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failurefn1fn1This work was supported in part by Grants AR-41391 and RR-006645 from the National Institutes of Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

The diagnosis of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteoporosis after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone mineral loss and recovery after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Mechanisms of rapid bone loss following cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

The course of biochemical parameters of bone turnover during treatment with corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Severe osteoporosis before and after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteopenia in adults with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone loss and reduced osteoblast function in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone disease in alcohol abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Ethanol inhibits human bone cell proliferation and function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone disease after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone fractures in liver transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone loss after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Sacral stress fracture after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Osteoporosis: trials and tribulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900081-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00081-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626030%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference